PDGFRB and cancer: VEGFR (vascular endothelial growth factor receptor) and PDGFR (platelet-derived growth factor receptor) inhibitors Sunitinib, Pazopanib, Cabozantinib, and Axitinib have become widely used in renal cell carcinoma (https://www.cancer.org/cancer/kidney-cancer/treating/targeted-therapy.html).